GoDaddy(GDDY) - 2025 Q4 - Annual Report
2026-02-24 23:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-36904 (Address of principal executive offices, including zip code) Securities registered pursuant to Section 1 ...
HP(HPQ) - 2026 Q1 - Quarterly Report
2026-02-24 23:31
Use these links to rapidly review the document Table of Contents Part I. Financial Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2026 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-4423 ____________________________ ...
Talos Energy(TALO) - 2025 Q4 - Annual Results
2026-02-24 23:28
Production and Reserves - Talos produced 64.9 thousand barrels of oil per day (MBo/d) and 89.2 thousand barrels of oil equivalent per day (MBoe/d) in Q4 2025, with full-year production of 65.9 MBo/d and 94.6 MBoe/d[5]. - Talos achieved a year-end 2025 proved reserves of 174.7 million barrels of oil equivalent (MMBoe) with a present value (PV-10) of $3.2 billion[5]. - Talos's probable reserves as of December 31, 2025, were 102.5 MMBoe, with a PV-10 value of approximately $2.3 billion[38]. - Production guidance for 2026 is expected to range from 62 to 66 MBo/d and 85 to 90 MBoe/d[40]. - For Q1 2026, production is estimated to be between 60 to 64 MBo/d and 84 to 88 MBoe/d[41]. Financial Performance - The company reported a net loss of $202.6 million, or $1.19 per diluted share, for Q4 2025, and a full-year net loss of $494.3 million, or $2.82 per diluted share, which included $170.4 million of non-cash impairment charges[5][22]. - Talos generated Adjusted EBITDA of $240.1 million in Q4 2025 and $1,198.6 million for the full year, with Adjusted Free Cash Flow of $21.3 million in Q4 and $417.7 million for the full year[5][22]. - Total revenues for Q4 2025 were $392.2 million, a decrease of 19.2% compared to $485.2 million in Q4 2024[60]. - Net loss attributable to Talos Energy Inc. for the year ended December 31, 2025, was $494.3 million, compared to a loss of $76.4 million in 2024[60]. - Operating expenses increased to $636.2 million in Q4 2025, up 38.9% from $458.0 million in Q4 2024[60]. Capital Expenditures and Investments - The company invested $150.4 million in capital expenditures in Q4 2025 and $498.6 million for the full year, excluding plugging and abandonment costs[5][22]. - Capital expenditures guidance for 2026 is projected to be between $500 million and $550 million, with P&A expenditures expected to range from $100 million to $130 million[40]. - Approximately 40% of total capital expenditures in 2026 will be non-operated, primarily driven by the Beacon-operated Monument project[40]. Shareholder Returns - The company repurchased approximately 1.5 million shares for $16.4 million in Q4 2025, and returned $119.1 million to shareholders through share repurchases in 2025, representing about 29% of annual free cash flow[5][16]. - Talos's capital allocation framework expects to allocate up to 50% of annual free cash flow to share repurchases, with a remaining authorization of approximately $81 million as of December 31, 2025[5][17]. Impairments and Charges - The company recorded a non-cash impairment charge of $170.4 million in Q4 2025 due to lower average oil prices, which does not impact cash flows[5][20]. - The impairment of oil and natural gas properties for Q4 2025 was $170,392 thousand, contributing to the overall net loss[82]. - The company reported an impairment of oil and natural gas properties of $454.5 million for the year ended December 31, 2025[62]. Debt and Liquidity - Total debt as of December 31, 2025, was $1,250.0 million, with net debt at $887.2 million, resulting in a net debt to pro forma LTM adjusted EBITDA ratio of 0.7x[32]. - Cash on hand as of December 31, 2025, was $362.8 million, providing total liquidity of $965.4 million[32]. - Long-term debt remained stable at approximately $1.23 billion in both 2025 and 2024, showing no significant change[58]. Assets and Equity - Total current assets rose to $841.3 million in 2025, compared to $659.4 million in 2024, reflecting an increase of 27.6%[58]. - Talos Energy's stockholders' equity decreased to $2.17 billion in 2025 from $2.76 billion in 2024, a decline of 21.4%[58]. - The company’s total assets decreased to $5.55 billion in 2025 from $6.19 billion in 2024, a decline of 10.4%[58]. Other Financial Metrics - Adjusted General & Administrative Expenses for the year ended December 31, 2025, were $134.0 million, compared to $155.4 million in 2024, reflecting a decrease of 13.8%[65]. - The company had a net cash increase of $224.6 million for the year ended December 31, 2025, compared to an increase of $78.4 million in 2024[62]. - Depreciation, depletion, and amortization expenses for the year ended December 31, 2025, were $1.2 billion, up from $1.1 billion in 2024[62].
Arcosa(ACA) - 2025 Q4 - Annual Results
2026-02-26 21:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 24, 2026 Arcosa, Inc. | __________________________________________ | | --- | | (Exact name of registrant as specified in its charter) | | | | (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 500 N. Akard Street, Suite 400 Dall ...
Evolent Health(EVH) - 2025 Q4 - Annual Report
2026-02-24 23:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-K _________________________ (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Registrant's telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: | Class A Common Stock of Evolent Health, Inc., par value $0.01 per share | EVH | New York Stock Exchange | | --- | --- | --- ...
CAVA (CAVA) - 2025 Q4 - Annual Report
2026-02-24 23:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number 001-41721 CAVA Group, Inc. (Exact name of registrant as specified in its charter) Delaware 47-3426661 (State or other juris ...
Hippo (HIPO) - 2025 Q4 - Annual Results
2026-02-24 23:05
Hippo Reports Fourth Quarter 2025 Financial Results February 25, 2026 SAN JOSE, Calif. (PRNewswire) -- Hippo Holdings Inc. (NYSE: HIPO), a technology-native insurance platform driving growth across owned and partner MGAs, announced its consolidated financial results including diluted earnings per share of $0.23 and diluted adjusted earnings per share of $0.67 for the quarter ended December 31, 2025. Fourth Quarter Highlights 2025 Full Year Highlights "We closed 2025 with strong momentum, evidenced by our 40 ...
SPX(SPXC) - 2025 Q4 - Annual Report
2026-02-24 22:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-6948 SPX Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 88-3567996 (State or other jurisdiction of ...
Hyliion (HYLN) - 2025 Q4 - Annual Report
2026-02-24 22:47
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File Number: 001-38823 HYLIION HOLDINGS CORP. (Exact name of registrant as specified in its charter) | Delaware ...
Hyliion (HYLN) - 2025 Q4 - Annual Results
2026-02-24 22:46
Exhibit 99.1 • On track to deliver initial KARNO units to customer sites and military applications in 2026, with plans to commercialize by year end • Operating five KARNO units at Hyliion's facility, supporting continuous validation, customer operations, and military testing • Expecting to secure $40 million to $50 million of follow-on U.S. military contracts in 2026 • Entering 2026 with strong demand across military and data center markets, including nearly 500 KARNO Cores under non-binding letters of inte ...